Effect of meditation on endothelial function in Black Americans with metabolic syndrome: a randomized trial.
Viola Vaccarino, Kofi A Kondwani, Mary E Kelley, Nancy V Murrah, Linda Boyd, Yusuf Ahmed, Yuan X Meng, Gary H Gibbons, W Craig Hooper, Christine De Staercke, Arshed A Quyyumi
Psychosomatic Medicine June 20, 2013 DOI: 10.1097/psy.0b013e31829ac4f4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 68 |
| Population | Black American adults aged 30-65 years with metabolic syndrome risk factors |
| Interventions | Consciously resting meditation (CRM) health education (HE) |
| Duration | 12 months |
| Measures | Brachial artery flow-mediated dilation, arterial elasticity |
| Topics | Meditation |
| Keywords | Brachial artery Endothelium, vascular Humans Risk factors Health education Vasodilation Elasticity Adult Middle aged Female Pulse wave analysis Metabolic syndrome Stress Obesity |
| Key findings | Consciously resting meditation did not improve endothelial function significantly more than a matched health education control over 12 months (p = .51 for group-by-time interaction). A risk factor score counting metabolic syndrome components decreased only in the meditation group (p = .049 for interaction), and most metabolic syndrome risk factors showed beneficial trends in that group only; these were secondary outcomes. |
Abstract
Objectives: Psychological stress may play a role in metabolic syndrome. A consequence of metabolic syndrome is endothelial dysfunction, which is also influenced by psychological stress. We sought to compare the effect of consciously resting meditation (CRM), a sound based meditation, with a control intervention of health education (HE) on endothelial function in the setting of metabolic syndrome.
Methods: Sixty-eight black Americans with metabolic syndrome risk factors (age, 30-65 years) were randomized to either CRM (n = 33) or HE (n = 35); interventions were matched for frequency and duration of sessions and lasted 12 months. Endothelial function was assessed by brachial artery flow-mediated dilation at baseline and at 6 and 12 months. Arterial elasticity, metabolic risk factors, and psychosocial and behavioral variables were secondary end points.
Results: Although flow-mediated dilation improved in the CRM group for 12 months, this increase was not significantly higher than that in the HE group (p = .51 for the interaction between group and time). Non-endothelium-dependent dilation and arterial elasticity did not change in either group. Most metabolic syndrome risk factors showed beneficial trends in the CRM group only. A risk factor score counting the number of metabolic syndrome components decreased in the CRM group only (p = .049 for the interaction between treatment group and time).
Conclusions: Among black Americans with metabolic syndrome risk factors, CRM, did not improve endothelial function significantly more than a control intervention of HE. CRM resulted in favorable trends in metabolic syndrome risk factors, which were examined as secondary outcomes.
Comparable studies
Other randomized controlled trials on meditation, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Alterations in Brain and Immune Function Produced by Mindfulness Meditation Healthy employees in a work environment | 2003 | Randomized controlled trial | n = 41 |
| Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients | 2000 | Randomized controlled trial | n = 145 |
| Open hearts build lives: Positive emotions, induced through loving-kindness meditation, build consequential personal resources. Working adults | 2008 | Randomized controlled trial | n = 139 |
| Short-term meditation training improves attention and self-regulation Undergraduate Chinese students | 2007 | Randomized controlled trial | n = 40 |
| Mindfulness-Based Cognitive Therapy for Depression: Replication and Exploration of Differential Relapse Prevention Effects. Recovered recurrently depressed patients | 2004 | Randomized controlled trial | n = 73 |
Citations in the library
Cited by 5
- Meditation for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews February 15, 2024
- Effects of Static Meditation Practice on Blood Lipid Levels: A Systematic Review and Meta-Analysis. Healthcare March 14, 2024
- Effectiveness of Mantra-Based Meditation on Mental Health: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health March 13, 2022
- Systematic Review for the Medical Applications of Meditation in Randomized Controlled Trials. International Journal of Environmental Research and Public Health January 22, 2022
- Meditation and Cardiovascular Risk Reduction: A Scientific Statement From the American Heart Association. Journal of the American Heart Association September 28, 2017
Cites 4
- Effects of a Randomized Controlled Trial of Transcendental Meditation on Components of the Metabolic Syndrome in Subjects With Coronary Heart Disease Archives of Internal Medicine June 12, 2006
- Impact of transcendental meditation on ambulatory blood pressure in African-American adolescents American Journal of Hypertension April 1, 2004
- A randomized controlled trial of stress reduction in African Americans treated for hypertension for over one year. American Journal of Hypertension January 2005
- Impact of Transcendental Meditation on cardiovascular function at rest and during acute stress in adolescents with high normal blood pressure. Journal of Psychosomatic Research October 1, 2001